SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

A reported exploit affecting NEAR Intents has prompted concern about cross-chain security and whether users will continue to trust the service. Traders are divided between treating the incident as contained and buying the dip, and worrying it could undermine NEARs adoption narrative.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit shares are drawing attention for their prolonged, volatile slide and repeated difficulty holding above the $150 area, with many traders questioning the decline despite citing the companys growth. Debate centers on insider selling and a lack of clarity around AI data-licensing deals, while bulls point to Reddits data value and the Anthropic case as potential positives.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastems RAMP 201 molecular-profiling and external-control analyses in recurrent low-grade serous ovarian cancer are drawing attention, with traders debating whether activity in KRAS wild-type patients could broaden the treatment opportunity. The discussion also looks ahead to VS-7375 clinical data, while some investors question why the positive developments have not translated into a stronger share price.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNBs recent rebound is drawing technical-trading attention, with repeated chart commentary describing consolidation near resistance. Traders are split between expecting further upside and anticipating a pullback after the gains.

Pump.fun

PUMPs rebound is drawing bullish attention, with traders pointing to the tokens revenue-funded buybacks and burns and renewed activity across Solanas memecoin ecosystem. Others remain skeptical, questioning the rallys staying power and describing the token as prone to sharp selloffs.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenuss BOT+BAL ovarian-cancer update, reporting an estimated 48% three-year survival in a heavily pretreated trial cohort, is driving attention. Many traders view the durability as encouraging and discuss possible FDA interest, while others caution that the Phase 1b results come from a small, nonrandomized study; debate also centers on dilution and the companys execution history.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Shareholder approval of Evernorths merger with Armada, paving the way for a Nasdaq debut as an XRP-treasury company holding roughly 473 million XRP, is driving attention. Traders are also focused on a sharp, low-float momentum run, with bulls citing the treasury and potential squeeze while skeptics warn the stock is trading well above its XRP backing and could face profit-taking.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Reports that OpenAIs latest ultrafast tier is using Nvidia GPUs rather than Cerebras hardware, combined with staged insider-share unlocks, have fueled concern about competition and selling pressure. Traders debate whether the report threatens Cerebras OpenAI relationshipSam Altman has described the companies as close partnerswhile bulls point to AI-inference demand and speculate on a rebound or short squeeze.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figmas sharp swings are fueling debate over whether strong growth, raised guidance and paid AI-feature adoption can outweigh concerns about AI competition, rising costs and selling from unlocked insider shares. Bulls also point to declining short interest and possible short-covering, while bears view the stocks volatility and continued selling pressure as signs of further weakness.

Lowe's Companies, Inc. engages in the retail sale of home improvement products. The firm offers products for maintenance, repair, remodeling, home decorating, and property maintenance. It also provides home improvement products in the following categories: appliances, seasonal & outdoor living, lumber, lawn & garden, kitchens & bath, hardware, building materials, millwork, paint, rough plumbing, tools, electrical, flooring, and décor. The company was founded in 1946 and is headquartered in Mooresville, NC.

Lowe`s Cos., Inc.

Lowe's Companies, Inc.

Lowes is drawing attention after sliding to fresh 52-week lows alongside home-improvement and housing stocks, with traders pointing to elevated Treasury yields, borrowing costs, and weak housing demand as sector headwinds. Some see the selloff as a buying opportunity in a quality dividend stock, while others warn that the decline may continue as rates and housing conditions remain unfavorable.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Omnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Strength Seen in Tempus (TEM): Can Its 14.9% Jump Turn into More Strength?

Tempus (TEM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Here's Why Omnicell (OMCL) is a Strong Value Stock

TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations

TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations PR Newswire BOSTON, Sept. 3, 2026 Integration brings serialized product verification and traceability directly...

Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference

Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026 at 12:45p.m. EDT. Live and archived webcasts of the...

Omnicell Becomes Oversold (OMCL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...

Why Omnicell (OMCL) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Omnicell President Sells 6,753 Shares

Key PointsThe disposal comprised 6,753 shares representing a total transaction value of ~$250,000...

Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins

OMCL raised its 2026 EPS outlook after a strong second quarter, but rising memory-chip costs and delayed hospital purchases could test margins.

OMCL Falls 20.1% in a Month as Booking and Margin Risks Build

Omnicell's 20.1% monthly slide reflects booking uncertainty, margin pressure and refresh-cycle risks despite a higher 2026 profit outlook.

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.

Omnicell, Inc.

Bearish Sentiment

Up more than 5%

Flat to up 5%

Flat to down 5%

Down more than 5%

What&#39;s your expected total return for the S&amp;P 500 ($SPY) in Q4? 

Drop your reasoning in the comments.

Stocktwits

What's your expected total return for the S&P 500 (

) in Q4? 

Drop your reasoning in the comments.

OMCL Omnicell, Inc.